CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bloomage Biotechnology Corp Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bloomage Biotechnology Corp Ltd
No.678 Tianchen Street
High-tech Development Zone
Phone: +86 1085670603p:+86 1085670603 JI'NAN, SDG  250101  China Ticker: 688363688363

Business Summary
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, General Manager YanZhao 56
Chief Financial Officer HuiWang 40 2/28/2024 2/28/2024
Deputy General Manager, Director, Chief Operating Officer JiajunGuo 47 12/1/2019 3/1/2019
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4,278 (As of 12/31/2022)
Outstanding Shares: 481,582,786 (As of 9/30/2023)
Shareholders: 35,878
Stock Exchange: SHA
Fax Number: +86 1065630000


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024